Philips introduces simplicity for a new generation of electrophysiology intervention labs

PHILIPSRoyal Philips Electronics (NYSE: PHG; AEX: PHI) announced the commercial release of Philips EP cockpit to support clinicians and staff in the treatment of cardiac rhythm disorders, including complex ablation therapies. This new concept in electrophysiology (EP) labs combines Philips proven Allura Xper interventional lab with a number of innovative instruments to help make EP labs more convenient and efficient by creating a more intuitive EP lab working environment and integrating data management across the EP care cycle.

Electrophysiology is one of the fastest growing market segments in cardiology. However, many EP departments are having difficulty dealing with the increasing demand for these procedures and the need to perform more complex patient treatments. EP procedures are highly specialized and require dedicated equipment and facilities, yet they are often performed in catheterization (cath) labs that are not specifically designed for this purpose. EP labs are frequently cluttered, temporary and inefficient. Working with many different systems in different places, EP professionals are struggling to find an efficient process. These issues make it a challenge to provide the best possible care to patients.

With this in mind, Philips set about developing an integrated solution which would provide EP specialists with a comfortable and efficient working environment to raise the level of heart rhythm care-EP cockpit. This new solution provides a customizable lab setup including video switching, single keyboard and mouse control concept, and moveable ceiling suspended equipment rack holding EP lab equipment.

Additionally, EP cockpit is equipped with an embedded data-management solution that can archive and retrieve patient data from various sources enabling physician access via a single workspace. EP cockpit can also be equipped with EP navigator, Philips' innovative imaging tool that will support clinicians in the treatment of complex cardiac rhythm disorders.

"By talking to our customers and observing them at work in the EP lab we realized that in many labs the working environment was far from optimal. The variety of technologies used in the EP lab can create a clutter of cables, keyboards and video screens that may take away attention from the procedure itself and from the patient," said Jan Vermeulen, global marketing manager, electrophysiology, for Philips Medical Systems. "Besides cleaning up the lab, EP cockpit also helps to manage data from the different sources in a more uniform way, thereby allowing electrophysiology professionals to work more efficiently and perform procedures with more confidence."

About Royal Philips Electronics
Royal Philips Electronics of the Netherlands (NYSE: PHG, AEX: PHI) is a global leader in healthcare, lifestyle and technology, delivering products, services and solutions through the brand promise of "sense and simplicity". Headquartered in the Netherlands, Philips employs approximately 124,300 employees in more than 60 countries worldwide. With sales of EUR 27 billion in 2006, the company is a market leader in medical diagnostic imaging and patient monitoring systems, energy efficient lighting solutions, personal care and home appliances, as well as consumer electronics. News from Philips is located at www.philips.com/newscenter.

Most Popular Now

Philips Foundation 2024 Annual Report: E…

Marking its tenth anniversary, Philips Foundation released its 2024 Annual Report, highlighting a year in which the Philips Foundation helped provide access to quality healthcare for 46.5 million people around...

New AI Transforms Radiology with Speed, …

A first-of-its-kind generative AI system, developed in-house at Northwestern Medicine, is revolutionizing radiology - boosting productivity, identifying life-threatening conditions in milliseconds and offering a breakthrough solution to the global radiologist...

Scientists Argue for More FDA Oversight …

An agile, transparent, and ethics-driven oversight system is needed for the U.S. Food and Drug Administration (FDA) to balance innovation with patient safety when it comes to artificial intelligence-driven medical...

New Research Finds Specific Learning Str…

If data used to train artificial intelligence models for medical applications, such as hospitals across the Greater Toronto Area, differs from the real-world data, it could lead to patient harm...

Giving Doctors an AI-Powered Head Start …

Detection of melanoma and a range of other skin diseases will be faster and more accurate with a new artificial intelligence (AI) powered tool that analyses multiple imaging types simultaneously...

AI Agents for Oncology

Clinical decision-making in oncology is challenging and requires the analysis of various data types - from medical imaging and genetic information to patient records and treatment guidelines. To effectively support...

Patients say "Yes..ish" to the…

As artificial intelligence (AI) continues to be integrated in healthcare, a new multinational study involving Aarhus University sheds light on how dental patients really feel about its growing role in...

Brains vs. Bytes: Study Compares Diagnos…

A University of Maine study compared how well artificial intelligence (AI) models and human clinicians handled complex or sensitive medical cases. The study published in the Journal of Health Organization...

'AI Scientist' Suggests Combin…

An 'AI scientist', working in collaboration with human scientists, has found that combinations of cheap and safe drugs - used to treat conditions such as high cholesterol and alcohol dependence...

Start-ups in the Spotlight at MEDICA 202…

17 - 20 November 2025, Düsseldorf, Germany. MEDICA, the leading international trade fair and platform for healthcare innovations, will once again confirm its position as the world's number one hotspot for...